Old Web
English
Sign In
Acemap
>
authorDetail
>
Ignacio Matos-García
Ignacio Matos-García
Hebron University
Pathology
Medicine
Oncology
Internal medicine
Thyroid cancer
3
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed.
2017
Journal of Gastrointestinal Cancer
Jorge Hernando Cubero
Ignacio Matos-García
Vicente Alonso Orduña
Jaume Capdevila
Show All
Source
Cite
Save
Citations (2)
A multicohort phase II study of durvalumab plus tremelimumab for the treatment of patients (PTS) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) or lung origin (the DUNE trial-GETNE1601-).
2017
Journal of Clinical Oncology
Ignacio Matos-García
Enrique Grande
Rocio Garcia-Carbonero
Carlos López
A. Teule
Jaume Capdevila
Show All
Source
Cite
Save
Citations (1)
RNAseq analysis of the sorafenib phase III DECISION trial in differentiated thyroid cancer (DTC): Correlation with clinical outcome.
2017
Journal of Clinical Oncology
Jaume Capdevila
Ignacio Matos-García
Francesco Mancuso
Carmela Iglesias
Paolo Nuciforo
Carles Zafon
Héctor G. Pálmer
Zighereda Ogbah
Laura Muiños
C. Pena
Marcia S. Brose
Martin Schlumberger
Ana Vivancos
Show All
Source
Cite
Save
Citations (1)
1